Showing results (1591-1600 of 1,718) with videos related to

Sort By:
Pageof 172
NPJ Precision Oncology|December 2, 2025
Who may omit locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: a failure-pattern-based strategy in the immunotherapy eraJia-Rui He, Yu-Xi Xiao, Lin-Fang Wu, et al.
Frontiers in Endocrinology|May 6, 2022
Single-Cell RNA Sequencing of Human Corpus Cavernosum Reveals Cellular Heterogeneity Landscapes in Erectile DysfunctionDong Fang, Xiao-Hui Tan, Wen-Peng Song, et al.
Computational and Structural Biotechnology Journal|September 27, 2024
Rapid profiling of carcinogenic types of Helicobacter pylori infection via deep learning analysis of label-free SERS spectra of human serumFen Li, Yu-Ting Si, Jia-Wei Tang, et al.
Nature Communications|January 14, 2015
Reciprocal inhibition between sensory ASH and ASI neurons modulates nociception and avoidance in Caenorhabditis elegansMin Guo, Tai-Hong Wu, Yan-Xue Song, et al.
Plos One|September 15, 2015
Long-Term Results of Concurrent Chemoradiotherapy for Advanced N2-3 Stage Nasopharyngeal CarcinomaLi Yin, Xiu-Hua Bian, Xue Wang, et al.
Chinese Medicine|September 20, 2025
The association between acupuncture and response to immune checkpoint inhibitors in non-small cell lung cancerRui Zhou, Yan-Juan Zhu, Yi-Han He, et al.
Physical Review Letters|November 17, 2023
Anisotropic Nonlocal Damping in Ferromagnet/α-GeTe Bilayers Enabled by Splitting Energy BandsXu Yang, Liang Qiu, Yan Li, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 9, 2022
Impact of salvage radiotherapy on survival of patients with advanced locally recurrent nasopharyngeal carcinoma: Derivation and validation of a predictive modelTing Liu, Bo-Wen Shen, Li-Ting Liu, et al.
Cancer Management and Research|August 3, 2019
The development of a nomogram to predict post-radiation necrosis in nasopharyngeal carcinoma patients: a large-scale cohort studyXiao-Yun Li, Xue-Song Sun, Sai-Lan Liu, et al.
Chinese Medical Journal|August 9, 2013
Evaluation of efficacy and safety of sunitinib regimen in 22 patients with metastatic renal cell carcinoma: at least 12-month follow-upCui-jian Zhang, Peng-ju Zhao, Xue-song Li, et al.
Pageof 172